Viking Therapeutics Inc (VKTX)
72.88
+0.34
(+0.47%)
USD |
NASDAQ |
Nov 01, 16:00
73.42
+0.54
(+0.74%)
After-Hours: 20:00
Viking Therapeutics Market Cap: 8.121B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 8.121B |
| October 31, 2024 | 8.084B |
| October 30, 2024 | 7.996B |
| October 29, 2024 | 8.174B |
| October 28, 2024 | 8.304B |
| October 25, 2024 | 8.695B |
| October 24, 2024 | 8.159B |
| October 23, 2024 | 6.730B |
| October 22, 2024 | 6.912B |
| October 21, 2024 | 7.170B |
| October 18, 2024 | 7.333B |
| October 17, 2024 | 7.200B |
| October 16, 2024 | 7.338B |
| October 15, 2024 | 7.286B |
| October 14, 2024 | 7.332B |
| October 11, 2024 | 7.337B |
| October 10, 2024 | 6.959B |
| October 09, 2024 | 6.980B |
| October 08, 2024 | 7.430B |
| October 07, 2024 | 7.022B |
| October 04, 2024 | 7.239B |
| October 03, 2024 | 7.144B |
| October 02, 2024 | 7.209B |
| October 01, 2024 | 6.909B |
| September 30, 2024 | 7.055B |
| Date | Value |
|---|---|
| September 27, 2024 | 6.828B |
| September 26, 2024 | 6.905B |
| September 25, 2024 | 6.995B |
| September 24, 2024 | 6.862B |
| September 23, 2024 | 7.203B |
| September 20, 2024 | 7.808B |
| September 19, 2024 | 7.552B |
| September 18, 2024 | 7.141B |
| September 17, 2024 | 6.974B |
| September 16, 2024 | 7.434B |
| September 13, 2024 | 7.393B |
| September 12, 2024 | 6.959B |
| September 11, 2024 | 6.740B |
| September 10, 2024 | 6.055B |
| September 09, 2024 | 6.069B |
| September 06, 2024 | 5.997B |
| September 05, 2024 | 6.137B |
| September 04, 2024 | 6.437B |
| September 03, 2024 | 6.469B |
| August 30, 2024 | 7.104B |
| August 29, 2024 | 6.941B |
| August 28, 2024 | 6.776B |
| August 27, 2024 | 6.804B |
| August 26, 2024 | 7.259B |
| August 23, 2024 | 7.161B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
163.26M
Minimum
Jun 16 2022
9.989B
Maximum
Mar 04 2024
1.603B
Average
506.78M
Median
Market Cap Benchmarks
| Amgen Inc | 171.59B |
| Eli Lilly and Co | 777.42B |
| Pfizer Inc | 159.18B |
| Structure Therapeutics Inc | 2.353B |
| Altimmune Inc | 479.02M |
Market Cap Related Metrics
| Price to Book Value | 8.910 |
| Price | 72.88 |
| Earnings Yield | -1.28% |